4-(3-(2H-1,2,3-triazol-2-yl)phenylamino)-2-(2-aminocyclohexylamino)pyrimidine-5-carboxamide,
P505-15,
PRT062607,
1370261-97-4,
PRT062607 (Hydrochloride),
PRT062607 Hydrochloride,
PRT062607 HCl,
PRT062607 (P505-15, BIIB057) HCl,
2-[[(1R,2S)-2-Aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-5-pyrimidinecarboxamide Hydrochloride,
P505-15 hydrochloride,
PRT062607,
1370261-96-3,
C19H23N9O.ClH,
SCHEMBL900878,
AOB87122,
EX-A1591,
KS-00000XG5,
prt062607-p505-15-hcl,
2672AH,
MFCD25976708,
s8032,
CS-1488,
BC600301,
HY-15323,
FT-0772444,
W-6092,
J-006951,
1370261-97-4,1370261-96-3(free base),
PRT062607 (P505-15, PRT2607, BIIB057) HCl,
P505-15 HCl salt, PRT062607 HCl salt,PRT-2607 HCl salt, BIIB-057 HCl salt,
5-Pyrimidinecarboxamide, 2-[[(1R,2S)-2-aminocyclohexyl]amino]-4-[[3-(2H-1,2,3-triazol-2-yl)phenyl]amino]-, hydrochloride (1:1),
RMNLLPXCNDZJMJ-IDVLALEDSA-N,
PRT062607 (P505-15 HCL),
1370261-97-4 (HCl),
A12731,
4-((4-(2H-1,2,3-triazol-2-yl)phenyl)amino)-2-(((1R,2S)-2-aminocyclohexyl)amino)pyrimidine-5-carboxamide hydrochloride,